Dolby Laboratories Inc has a consensus price target of $71.33, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from Rosenblatt, Rosenblatt, and Rosenblatt on January 31, 2024, December 11, 2023, and November 17, 2023. With an average price target of $98 between Rosenblatt, Rosenblatt, and Rosenblatt, there's an implied 23.74% upside for Dolby Laboratories Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
01/31/2024 | DLB | Buy Now | Dolby Laboratories | $79.20 | 23.74% | Rosenblatt | Steve Frankel | → $98 | Reiterates | Buy → Buy | Get Alert |
12/11/2023 | DLB | Buy Now | Dolby Laboratories | $79.20 | 23.74% | Rosenblatt | Steve Frankel | → $98 | Reiterates | Buy → Buy | Get Alert |
11/17/2023 | DLB | Buy Now | Dolby Laboratories | $79.20 | 23.74% | Rosenblatt | Steve Frankel | → $98 | Reiterates | Buy → Buy | Get Alert |
08/04/2023 | DLB | Buy Now | Dolby Laboratories | $79.20 | 23.74% | Rosenblatt | Steve Frankel | $93 → $98 | Maintains | Buy | Get Alert |
07/28/2023 | DLB | Buy Now | Dolby Laboratories | $79.20 | 17.42% | Rosenblatt | Steve Frankel | → $93 | Reiterates | Buy → Buy | Get Alert |
06/01/2023 | DLB | Buy Now | Dolby Laboratories | $79.20 | 17.42% | Rosenblatt | Steve Frankel | → $93 | Reiterates | Buy → Buy | Get Alert |
04/26/2023 | DLB | Buy Now | Dolby Laboratories | $79.20 | 13.64% | Rosenblatt | Steve Frankel | → $90 | Reiterates | → Buy | Get Alert |
04/14/2023 | DLB | Buy Now | Dolby Laboratories | $79.20 | 46.46% | Tigress Financial | Ivan Feinseth | → $116 | Reiterates | → Buy | Get Alert |
02/03/2023 | DLB | Buy Now | Dolby Laboratories | $79.20 | 13.64% | Rosenblatt | Steve Frankel | $85 → $90 | Maintains | Buy | Get Alert |
11/18/2022 | DLB | Buy Now | Dolby Laboratories | $79.20 | — | Barrington Research | James Goss | — | Downgrade | Outperform → Market Perform | Get Alert |
11/07/2022 | DLB | Buy Now | Dolby Laboratories | $79.20 | 7.32% | Rosenblatt | Steve Frankel | $90 → $85 | Maintains | Buy | Get Alert |
10/14/2022 | DLB | Buy Now | Dolby Laboratories | $79.20 | 46.46% | Tigress Financial | Ivan Feinseth | $128 → $116 | Maintains | Buy | Get Alert |
05/24/2022 | DLB | Buy Now | Dolby Laboratories | $79.20 | 13.64% | Rosenblatt | Steve Frankel | → $90 | Initiates | → Buy | Get Alert |
08/02/2021 | DLB | Buy Now | Dolby Laboratories | $79.20 | 45.2% | Barrington Research | James Goss | — | Upgrade | Market Perform → Outperform | Get Alert |
The latest price target for Dolby Laboratories (NYSE: DLB) was reported by Rosenblatt on January 31, 2024. The analyst firm set a price target for $98.00 expecting DLB to rise to within 12 months (a possible 23.74% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Dolby Laboratories (NYSE: DLB) was provided by Rosenblatt, and Dolby Laboratories reiterated their buy rating.
The last upgrade for Dolby Laboratories Inc happened on August 2, 2021 when Barrington Research raised their price target to $115. Barrington Research previously had a market perform for Dolby Laboratories Inc.
The last downgrade for Dolby Laboratories Inc happened on November 18, 2022 when Barrington Research changed their price target from N/A to N/A for Dolby Laboratories Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dolby Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dolby Laboratories was filed on January 31, 2024 so you should expect the next rating to be made available sometime around January 31, 2025.
While ratings are subjective and will change, the latest Dolby Laboratories (DLB) rating was a reiterated with a price target of $0.00 to $98.00. The current price Dolby Laboratories (DLB) is trading at is $79.20, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.